Navigation Links
Ukraine's First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
Date:6/24/2008

- Chair of 'Ukraine 3000 International Charitable Foundation' honored for

her work to improve healthcare for Ukrainian children, women -

WASHINGTON, June 24 /PRNewswire/ -- Ukraine's "First Lady," American-born Kateryna Yushchenko has been awarded the first-ever MaxWell International Public Health Award for 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )

The award is presented by MaxWell Biocorporation to an international public figure or organization that has made outstanding contributions to improving the health of under-served populations and demonstrated decisive leadership on public health issues.

Mrs. Yushchenko was chosen as the first recipient of the award in recognition of her service as Chair of the Ukraine 3000 International Charitable Foundation, her efforts on behalf of Ukraine's children, and her leadership in promoting early detection and treatment of breast cancer among Ukrainian women.

"Improved medical care in Ukraine is a priority for my husband, President Victor Yushchenko, and for my Foundation 'Ukraine 3000.' The health care sector in Ukraine is undergoing major change and improvement, but still needs much reform, investment, and training to bring it up to European standards," Mrs. Yushchenko wrote in a May 18 letter to Dr. Alibek.

"We appreciate MaxWell Biocorporation's investments into the Ukrainian health care sector and its efforts to provide Ukrainians with affordable, high quality pharmaceutical products and medical services," she added.

Dr. Ken Alibek, founder, President and CEO of MaxWell Biocorporation, presented the award to Mrs. Yushchenko during the opening of the MaxWell USA symposium "21st Century Pharmaceutical Production and Health Care Research & Delivery in the CIS." The symposium was held at the Ritz-Carlton in Washington, D.C. on May 28 (http://www.max-well.com/eng/press_whale.php).

Ukrainian Ambassador to the United States Oleh Shamshur received the award on behalf of Mrs. Yushchenko (http://www.max-well.com/img/photogallery/picture032_1.jpg).

About MaxWell

MaxWell Biocorporation is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union. MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."

"We Help You Live Longer"

Contact:

Alex Meerovich

A.Meerovich@max-well.com

202-454-3403


'/>"/>
SOURCE MaxWell Biocorporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: